Home › Thyroid Cancer › Massachusetts › Boston
Thyroid Cancer clinical trials in Boston, MA
6 studies for Thyroid Cancer are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecruitingPhase 1/2
- Dana-Farber Cancer Institute, Boston
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
RecruitingPhase 1
- Dana Farber/Harvard Cancer Center, Boston
Hereditary Risk Factors for Thyroid Cancer
RecruitingHealthy volunteers welcome
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- Massachusetts General Hospital,, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Massachusetts General Hospital, Boston
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
RecruitingPhase 2
- Massachusetts General Hospital, Boston
About Thyroid Cancer
Your thyroid is a butterfly-shaped gland in your neck. There are several thyroid cancer types with different treatments. Discover options available.
More about Thyroid Cancer on MedlinePlus
Thyroid Cancer trials in other cities
- Houston, TX12 studies
- Washington, DC10 studies
- New York City, NY9 studies
- Philadelphia, PA6 studies
- Durham, NC5 studies
- Nashville, TN5 studies
- Los Angeles, CA5 studies
- San Francisco, CA4 studies
- Ann Arbor, MI4 studies
- Minneapolis, MN4 studies
- Memphis, TN4 studies
- San Antonio, TX4 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer60 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.